Autopsy report · NCT04305678

Mepolizumab for Eosinophilic Fasciitis

“Funding lost from Sponsor.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Eosinophilic Fasciitis

Interventions

Mepolizumab

Participants

0

Trials that died the same way

• A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure
  “Sponsor lost funding” (95% match in meaning)
• Effects of Neuro-Stim System on Pain, Sleep, and Opioid Use
  “Lost funding from sponsor” (93% match in meaning)
• Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD
  “Loss of funding” (86% match in meaning)
• Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
  “Funding loss” (86% match in meaning)
• Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
  “Sponsor withdrew funding.” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.